Some publications indicated that OX1R antagonists produced enhancement of depression-like behavior, while orexin A administration induces anti-depressive-like effects (Ito et al., 2008; Scott et al., 2011), which is consistent with our results showing that OX1R might be involved in the regulation of depression-like behavior. This evidence concerns the gene HCRT and depressive symptom measurement.